NasdaqCM - Delayed Quote USD
Entero Therapeutics, Inc. (ENTO)
0.4920
+0.0443
+(9.90%)
At close: June 5 at 4:00:01 PM EDT
0.4642
-0.03
(-5.65%)
After hours: June 5 at 7:38:49 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 117.09k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ROMANO SARAH M. Chief Financial Officer | Sale at price 0.64 per share. | Direct | 465 | Jan 6, 2025 |
| ROMANO SARAH M. Chief Financial Officer | Sale at price 0.45 per share. | Direct | 212 | Oct 9, 2024 |
| SAPIRSTEIN JAMES E Chief Executive Officer | Sale at price 1.07 per share. | Direct | 1,379 | Jul 2, 2024 |
| ROMANO SARAH M. Chief Financial Officer | Sale at price 1.07 per share. | Direct | 664 | Jul 2, 2024 |
| KHOSLA CHAITAN S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| SAPIRSTEIN JAMES E Chief Executive Officer | Sale at price 4.23 per share. | Direct | 736 | Apr 1, 2024 |
| ROMANO SARAH M. Chief Financial Officer | Sale at price 4.23 per share. | Direct | 317 | Apr 1, 2024 |
| SAPIRSTEIN JAMES E Chief Executive Officer | Sale at price 4.96 per share. | Direct | 9,360 | Mar 15, 2024 |
| ROMANO SARAH M. Chief Financial Officer | Sale at price 4.96 per share. | Direct | 5,555 | Mar 15, 2024 |
| SYAGE JACK PH.D. President | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Mar 13, 2024 |
| KHOSLA CHAITAN S Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Mar 13, 2024 |
| SAPIRSTEIN JAMES E Chief Executive Officer | Sale at price 4.20 per share. | Direct | 697 | Jan 12, 2024 |
| ROMANO SARAH M. Chief Financial Officer | Sale at price 4.20 per share. | Direct | 412 | Jan 12, 2024 |
| COELHO MARY THERESA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| BORKOWSKI EDWARD J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| CASAMENTO CHARLES J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| BORKOWSKI EDWARD J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| SAPIRSTEIN JAMES E Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| RIDDELL ALASTAIR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| ROMANO SARAH M. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
| SAPIRSTEIN JAMES E Chief Executive Officer | Sale at price 0.29 per share. | Direct | 802 | Oct 4, 2023 |
| ROMANO SARAH M. Chief Financial Officer | Sale at price 0.29 per share. | Direct | 486 | Oct 4, 2023 |
| CASAMENTO CHARLES J Director | Sale at price 0.43 per share. | Direct | 4 | Sep 15, 2023 |
| CASAMENTO CHARLES J Director | Sale at price 0.30 per share. | Direct | 1,816 | Aug 31, 2023 |
| SAPIRSTEIN JAMES E Chief Executive Officer | Sale at price 1.54 per share. | Direct | 5,157 | Jul 3, 2023 |
| ROMANO SARAH M. Chief Financial Officer | Sale at price 1.54 per share. | Direct | 3,045 | Jul 3, 2023 |
Related Tickers
MTNB Matinas BioPharma Holdings, Inc.
0.8772
+5.67%
ZVSA ZyVersa Therapeutics, Inc.
0.6452
+3.96%
BCLI Brainstorm Cell Therapeutics Inc.
1.1300
+0.89%
PCSA Processa Pharmaceuticals, Inc.
0.2903
-5.62%
BDRX Biodexa Pharmaceuticals Plc
1.1500
-0.86%
ENVB Enveric Biosciences, Inc.
1.2600
-2.33%
KAPA Kairos Pharma, Ltd.
0.5025
-3.48%
INTS Intensity Therapeutics, Inc.
0.4485
-4.98%
RENB Renovaro Inc.
0.3128
+5.60%
TNFA TNF Pharmaceuticals, Inc.
0.1596
-2.62%